CXC Chemokine Receptor 3 and CC Chemokine Receptor 4 Expression in T-Cell and NK-Cell Lymphomas with Special Reference to Clinicopathological Significance for Peripheral T-Cell Lymphoma, Unspecified-Reference-Cited by-同舟云学术

CXC Chemokine Receptor 3 and CC Chemokine Receptor 4 Expression in T-Cell and NK-Cell Lymphomas with Special Reference to Clinicopathological Significance for Peripheral T-Cell Lymphoma, Unspecified

Published:2004-08-15 Issue:16 Volume:10 Page:5494-5500
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Ishida Takashi,Inagaki Hiroshi,Utsunomiya Atae,Takatsuka Yoshifusa,Komatsu Hirokazu,Iida Shinsuke,Takeuchi Genji,Eimoto Tadaaki,Nakamura Shigeo,Ueda Ryuzo

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and effectiveness of mogamulizumab in relapsed or refractory CC chemokine receptor 4‐positive peripheral T‐cell lymphoma and relapsed or refractory cutaneous T‐cell lymphoma: A post‐marketing surveillance in Japan;Hematological Oncology;2024-06-07

2. Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma;Journal of Hematology & Oncology;2024-06-01

3. Reduced CC Chemokine Receptor 4 Expression in Tumor Cells after Lenalidomide Treatment for Adult T-Cell Leukemia/Lymphoma: A Case Report;Case Reports in Oncology;2024-05-30

4. Clinicopathological implications of immunohistochemical expression of TBX21, CXCR3, GATA3, CCR4, and TCF1 in nodal follicular helper T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified;Journal of Pathology and Translational Medicine;2024-03-15

5. Immune modulation in malignant pleural effusion: from microenvironment to therapeutic implications;Cancer Cell International;2024-03-12